AC IMMUNE SA's ticker is ACIU and the CUSIP is H00263105. A total of 42 filers reported holding AC IMMUNE SA in Q1 2019. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $0 | -100.0% | 158 | 0.0% | 0.00% | – |
| Q2 2022 | $1,000 | 0.0% | 158 | 0.0% | 0.00% | – |
| Q1 2022 | $1,000 | 0.0% | 158 | 0.0% | 0.00% | – |
| Q4 2021 | $1,000 | 0.0% | 158 | 0.0% | 0.00% | – |
| Q3 2021 | $1,000 | 0.0% | 158 | 0.0% | 0.00% | – |
| Q2 2021 | $1,000 | 0.0% | 158 | 0.0% | 0.00% | – |
| Q1 2021 | $1,000 | 0.0% | 158 | 0.0% | 0.00% | – |
| Q4 2020 | $1,000 | -50.0% | 158 | -62.8% | 0.00% | – |
| Q3 2020 | $2,000 | -93.8% | 425 | 0.0% | 0.00% | -100.0% |
| Q2 2020 | $32,000 | +966.7% | 425 | 0.0% | 0.00% | – |
| Q1 2020 | $3,000 | 0.0% | 425 | 0.0% | 0.00% | – |
| Q4 2019 | $3,000 | +50.0% | 425 | 0.0% | 0.00% | – |
| Q3 2019 | $2,000 | 0.0% | 425 | 0.0% | 0.00% | – |
| Q2 2019 | $2,000 | -66.7% | 425 | -29.2% | 0.00% | – |
| Q4 2018 | $6,000 | – | 600 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| BVF INC/IL | 7,428,379 | $21,170,880 | 0.57% |
| Avidity Partners Management LP | 2,969,800 | $8,463,930 | 0.34% |
| PLATINUM INVESTMENT MANAGEMENT LTD | 1,322,462 | $3,769,017 | 0.15% |
| Eversept Partners, LP | 124,589 | $355,079 | 0.03% |
| COHEN LAWRENCE B | 12,850 | $36,623 | 0.02% |
| Banque Cantonale Vaudoise | 80,701 | $231 | 0.01% |
| Renaissance Technologies | 425,179 | $1,212 | 0.00% |
| Handelsbanken Fonder AB | 101,064 | $288 | 0.00% |
| Tower Research Capital LLC (TRC) | 19,638 | $55,968 | 0.00% |
| Compagnie Lombard Odier SCmA | 10,000 | $28,500 | 0.00% |